Organon & Co.
Organon & Co.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1,132 | 1,116 | 574 | 672 | 599 | 547 | 675 | 763 | 704 | 575 | 693 | 414 | |||||
Accounts Receivable Net Current | 1,492 | 1,384 | 1,331 | 1,484 | 1,484 | 1,457 | 1,358 | 1,685 | 1,617 | 1,547 | 1,744 | 1,648 | |||||
Inventory Net | 1,351 | 1,373 | 1,406 | 1,488 | 1,454 | 1,362 | 1,321 | 1,383 | 1,287 | 1,263 | 1,315 | 1,186 | |||||
Other Assets Current | 1,136 | 1,059 | 1,033 | 1,056 | 1,081 | 1,005 | 994 | 925 | 901 | 811 | 756 | 802 | |||||
Assets Of Disposal Group Including Discontinued Op… | 0 | 0 | 8 | - | - | - | 0 | - | - | - | - | - | |||||
Assets Current | 5,111 | 4,932 | 4,352 | 4,700 | 4,618 | 4,371 | 4,348 | 4,756 | 4,509 | 4,196 | 4,508 | 4,050 | |||||
Property Plant And Equipment Net | 1,281 | 1,279 | 1,303 | 1,290 | 1,266 | 1,197 | 1,168 | 1,204 | 1,162 | 1,180 | 1,183 | 1,096 | |||||
Goodwill | 4,153 | 4,153 | 4,153 | 4,680 | 4,680 | 4,680 | 4,680 | 4,603 | 4,603 | 4,603 | 4,603 | 4,603 | |||||
Finite Lived Intangible Assets Net | 1,112 | 1,099 | 1,130 | 1,340 | 1,362 | 1,417 | 1,414 | 763 | 684 | 718 | 533 | 561 | |||||
Deferred Income Taxes And Other Assets Noncurrent | 1,521 | 1,533 | 1,539 | 1,542 | 1,574 | 1,491 | 1,491 | 1,426 | 1,196 | 1,194 | 1,231 | 702 | |||||
Disposal Group Including Discontinued Operation As… | 0 | 0 | 390 | - | - | - | 0 | - | - | - | - | - | |||||
Assets | 13,178 | 12,996 | 12,867 | 13,552 | 13,500 | 13,156 | 13,101 | 12,752 | 12,154 | 11,891 | 12,058 | 11,012 | |||||
Long Term Debt Current | - | - | - | - | - | 20 | 20 | 10 | 9 | 9 | 9 | 8 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Debt Current | 74 | 16 | 16 | 45 | 115 | - | 20 | - | - | - | - | - | |||||
Accounts Payable Current | 1,051 | 983 | 952 | 1,074 | 1,067 | 1,006 | 1,153 | 1,092 | 1,243 | 955 | 1,314 | 1,067 | |||||
Accrued Income Taxes Current | 84 | 77 | 85 | 116 | 194 | 176 | 134 | 230 | 201 | 196 | 206 | 161 | |||||
Liabilities Of Disposal Group Including Discontinu… | 0 | 0 | 2 | - | - | - | 0 | - | - | - | - | - | |||||
Liabilities Current | 2,616 | 2,500 | 2,390 | 2,679 | 2,796 | 2,615 | 2,718 | 2,790 | 2,755 | 2,545 | 2,918 | 2,491 | |||||
Long Term Debt Noncurrent | 8,479 | 8,553 | 8,628 | 8,783 | 8,781 | 8,936 | 8,860 | 8,739 | 8,647 | 8,705 | 8,751 | 8,646 | |||||
Deferred Income Tax Liabilities Net | 51 | 56 | 57 | 62 | 69 | 69 | 74 | 56 | 60 | 44 | 47 | 43 | |||||
Other Liabilities Noncurrent | 1,026 | 984 | 1,008 | 1,122 | 1,121 | 994 | 977 | 674 | 548 | 549 | 412 | 421 | |||||
Liabilities Of Disposal Group Including Discontinu… | 0 | 0 | 32 | - | - | - | 0 | - | - | - | - | - | |||||
Liabilities | 12,172 | 12,093 | 12,115 | 12,646 | 12,767 | 12,614 | 12,629 | 12,259 | 12,010 | 11,843 | 12,128 | 11,601 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Additional Paid In Capital Common Stock | 199 | 186 | 167 | 159 | 139 | 130 | 108 | 86 | 63 | 49 | 25 | - | |||||
Retained Earnings Accumulated Deficit | 1,352 | 1,253 | 1,109 | 1,318 | 1,163 | 1,026 | 1,010 | 975 | 690 | 573 | 443 | -16 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -548 | -539 | -527 | -574 | -572 | -617 | -649 | -571 | -612 | -577 | -541 | -576 | |||||
Stockholders Equity | 1,006 | 903 | 752 | 906 | 733 | 542 | 472 | 493 | 144 | 48 | -70 | -589 | |||||
Liabilities And Stockholders Equity | 13,178 | 12,996 | 12,867 | 13,552 | 13,500 | 13,156 | 13,101 | 12,752 | 12,154 | 11,891 | 12,058 | 11,012 | |||||
Allowance For Doubtful Accounts Receivable Current | 13 | 14 | 12 | 12 | 12 | 12 | 14 | 13 | 10 | 11 | 9 | 9 | |||||
Inventory Noncurrent | 273 | 252 | 236 | 247 | 240 | 207 | 215 | 130 | 113 | 101 | 110 | 95 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 263 | 263 | 260 | 260 | 260 | 258 | 258 | 258 | 257 | 256 | 256 | 256 | |||||
Shares Outstanding | 263 | 263 | 260 | 260 | 260 | 258 | 258 | 258 | 257 | 256 | 256 | 256 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.75% | 1.96% | 2.11% | - | - | - | - | - | - | - | - | - |
| 2025 | -9.18% | 1.90% | -1.13% | 8.26% | 17.34% | 5.27% | -7.14% | -5.84% | 11.06% | -25.92% | 19.90% | 64.87% |
| 2024 | 8.52% | 7.74% | 8.47% | 18.97% | 2.10% | -8.66% | -13.94% | -17.88% | -11.35% | 3.22% | -25.42% | -39.23% |
| 2023 | - | - | - | -3.22% | -24.11% | -34.60% | -12.44% | 7.22% | 19.47% | 0.74% | 0.96% | 25.22% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.95 | 1.97 | 1.82 | 1.75 | 1.65 | 1.67 | 1.60 | 1.70 | 1.64 | 1.65 | 1.54 | 1.63 | |||||
| Quick Ratio | 1.44 | 1.42 | 1.23 | 1.20 | 1.13 | 1.15 | 1.11 | 1.21 | 1.17 | 1.15 | 1.09 | 1.15 | |||||
| Working Capital | 2.50B | 2.43B | 1.96B | 2.02B | 1.82B | 1.76B | 1.63B | 1.97B | 1.75B | 1.65B | 1.59B | 1.56B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 12.10 | 13.39 | 16.11 | 13.96 | 17.42 | 23.27 | 26.76 | 24.87 | 83.40 | 246.73 | -173.26 | -19.70 | |||||
| Interest Coverage TTM | 2.05 | 2.09 | 1.84 | 2.36 | 2.30 | 2.31 | 2.55 | 2.51 | 2.25 | 2.28 | 2.28 | 2.32 | |||||
| Debt Ratio | 0.92 | 0.93 | 0.94 | 0.93 | 0.95 | 0.96 | 0.96 | 0.96 | 0.99 | 1.00 | 1.01 | 1.05 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.46 | 0.47 | 0.48 | 0.48 | 0.49 | 0.50 | 0.51 | 0.54 | 0.55 | 0.56 | 0.54 | 0.57 | |||||
| Days Sales Outstanding TTM | 88.64 | 84.13 | 78.95 | 91.79 | 90.10 | 87.10 | 88.41 | 94.91 | 94.59 | 86.03 | 93.80 | 91.64 | |||||
| Receivables Turnover TTM | 4.12 | 4.34 | 4.62 | 3.98 | 4.05 | 4.19 | 4.13 | 3.85 | 3.86 | 4.24 | 3.89 | 3.98 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.77 | 0.94 | 0.72 | 1.92 | 2.69 | 2.87 | 3.33 | 5.01 | 3.87 | 4.05 | 3.99 | 2.28 | |||||
| Free Cash Flow Per Share TTM | 2.16 | 2.62 | 2.07 | 2.99 | 2.53 | 3.01 | 2.97 | 2.90 | 3.32 | 1.99 | 2.15 | 1.70 | |||||
| Dividend Per Share TTM | 0.07 | 0.08 | 0.34 | 0.61 | 0.88 | 1.16 | 1.16 | 1.15 | 1.15 | 1.14 | 1.15 | 1.15 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 52.68% | 52.82% | 53.30% | 55.04% | 56.26% | 57.18% | 58.02% | 73.21% | 73.68% | 74.13% | 75.14% | 60.55% | |||||
| Operating Profit Margin TTM | 8.01% | 8.71% | 6.84% | 11.14% | 10.60% | 10.68% | 12.60% | 12.20% | 10.32% | 10.62% | 10.75% | 11.06% | |||||
| Net Profit Margin TTM | 3.41% | 3.99% | 3.01% | 7.95% | 11.14% | 11.92% | 13.49% | 20.30% | 15.76% | 16.50% | 16.33% | 9.51% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -2.45% | -2.08% | -2.92% | -1.69% | -1.02% | -0.84% | 2.24% | 4.21% | 2.89% | 3.29% | 1.44% | -2.26% | |||||
| Net Income Growth (1Y) | -70.14% | -67.20% | -78.36% | -61.49% | -30.00% | -28.37% | -15.54% | 122.39% | 32.63% | 40.35% | 11.56% | -42.14% | |||||
| EPS Growth (1Y) | -70.45% | -67.52% | -78.56% | -61.86% | -30.71% | -28.97% | -16.14% | 120.74% | 31.62% | 39.63% | 11.05% | -42.42% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 16.99 | 6.32 | 9.90 | 5.50 | 3.56 | 5.06 | 4.30 | 3.61 | 5.00 | 4.26 | 3.28 | 6.75 | |||||
| P/B TTM | 3.53 | 1.72 | 2.46 | 3.04 | 3.40 | 7.00 | 7.88 | 9.52 | 34.75 | 92.81 | -47.99 | -6.71 | |||||
| P/S TTM | 0.58 | 0.25 | 0.30 | 0.44 | 0.40 | 0.60 | 0.58 | 0.73 | 0.79 | 0.70 | 0.54 | 0.64 | |||||
| Market Cap | 3.55B | 1.56B | 1.85B | 2.75B | 2.49B | 3.79B | 3.72B | 4.69B | 5.00B | 4.46B | 3.36B | 3.95B | |||||
| Enterprise Value | 10.97B | 9.01B | 9.92B | 10.91B | 10.79B | 12.20B | 11.92B | 12.68B | 12.96B | 12.59B | 11.43B | 12.19B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 567.00M | 683.00M | 538.00M | 777.00M | 658.00M | 777.00M | 764.00M | 747.00M | 854.00M | 510.00M | 548.00M | 434.00M | |||||
| Net Debt | 7.42B | 7.45B | 8.07B | 8.16B | 8.30B | 8.41B | 8.21B | 7.99B | 7.95B | 8.14B | 8.07B | 8.24B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Organon & Co. (OGN) — SEC Financial Statements & Analysis
Organon & Co. (OGN) is a pharmaceutical preparations company. Organon & Co. trades on NYSE as: OGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Organon & Co. reported a -2.45% year-over-year revenue growth, a Gross Profit Margin of 52.68% (TTM), a Debt-to-Equity ratio of 12.10x, a Price-to-Sales (P/S) ratio of 0.58x (TTM), a Price-to-Book (P/B) ratio of 3.53x (TTM), at a market cap of $3.55B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -2.45%
- Gross Profit Margin TTM
- 52.68%
- Debt To Equity
- 12.10x
- P/S TTM
- 0.58x
- P/B TTM
- 3.53x
- Market Cap
- $3.55B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Organon & Co. in?
Organon & Co. (OGN) operates in the Pharmaceutical Preparations industry.
What is OGN's market cap?
Organon & Co. (OGN) has a market capitalization of $3.55B as of 2026-06-30.
What is OGN's P/E ratio?
Organon & Co. (OGN)'s trailing twelve month P/E ratio is 16.99x as of 2026-06-30.
What exchange does OGN trade on?
Organon & Co. (OGN) trades on the NYSE.